And we further found that NCAPG displayed moderate cytoplasmic positivity, especially strongly staining in lymphoma, testicular, colorectal, and endometrial cancers while weakly stained in gliomas and prostate cancer (Figure 1(b)). This evidence concerns the gene NCAPG and prostate carcinoma.